Person: DANSUK, RAMAZAN
Loading...
Status
Kurumdan Ayrılmıştır
Email Address
Birth Date
Name
Job Title
First Name
RAMAZAN
Last Name
DANSUK
Organizational Units
28 results
Search Results
Now showing 1 - 10 of 28
Publication Open Access Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.(2015-06-01) DANSUK, RAMAZAN; GONENC, AI; SUDOLMUS, S; YUCEL, O; Sevket, OSMAN; KÖROĞLU, N; DANSUK, RAMAZAN; ŞEVKET, OSMANIntroduction: Intrauterine insemination (IUI) after controlled ovarian hyperstimulation (COH) was applied to selected infertile patients to determine the effect of gonadotropin-releasing hormone (GnRH) antagonists in IUI cycles, in which recombinant follicle-stimulating hormone (rFSH) had been used for COH. Methods: This study was conducted between April 1, 2009 and June 10, 2009, and involved a total of 108 patients. These patients had primary or secondary infertility, which resulted in an indication for IUI, and they each received two cycles of ovarian stimulation treatment with clomiphene citrate. The patients were randomised into two groups--patients in group A received rFSH + GnRH antagonist (n = 45), while those in group B received only rFSH (n = 63). Results: The mean age of the patients was 31.84 ± 3.73 years and the mean body mass index (BMI) was 24.40 ± 1.88 kg/m(2). The mean age and BMI of the patients in groups A and B were not significantly different. There was no significant difference in the mean total rFSH dose administered (988.33 IU in group A and 871.83 IU in group B). When compared to group B, the mean number of follicles that were > 16 mm on the human chorionic gonadotropin (HCG) trigger day was significantly higher in group A (1.58 and 1.86, respectively; p < 0.05). When the two groups were compared, there were no statistically significant differences in the number of cancelled cycles due to premature luteinisation (none in group A vs. two in group B) and the rate of clinical pregnancy (8.9% in group A vs. 7.9% in group B). Conclusion: No significant improvement in the clinical pregnancy rates was observed when GnRH antagonists were used in COH + IUI cycles, despite the significant increase in the number of follicles that were > 16 mm on HCG trigger day.Publication Metadata only The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus.(2014-11-01) Sevket, OSMAN; SEVKET, A; OZEL, A; DANSUK, RAMAZAN; KELEKCI, S; ŞEVKET, OSMAN; DANSUK, RAMAZANPublication Open Access Can CA-125 Predict Lymph Node Metastasis in Epithelial Ovarian Cancers in Turkish Population?(2014-01-01T00:00:00Z) Sudolmus, Sinem; Koroglu, Nadiye; Yildirim, Gokhan; Ulker, Volkan; Gulkilik, Ahmet; DANSUK, RAMAZAN; DANSUK, RAMAZANObjective. The role of single preoperative serum CA-125 levels in predicting pelvic or paraaortic lymph node metastasis in patients operated for epithelial ovarian cancer has been investigated. Methods. 176 patients diagnosed with epithelial ovarian carcinoma after staging laparotomy between January 2002 and May 2010 were evaluated retrospectively. Results. The mean, geometric mean, and median of preoperative serum CA-125 levels were 632,6, 200,29, and 191,5 U/mL, respectively. The cut-off value predicting lymph node metastases in the ROC curve was 71,92 U/mL, which is significant in logistic regression analysis (P = 0.005). The preoperative log CA-125 levels were also statistically significant in predicting lymph node metastasis in logistic regression analysis (P = 0.008). Conclusions. The tumor marker CA-125, which increases with grade independent of the effect of stage in EOC, is predictive of lymph node metastasis with a high rate of false positivity in Turkish population. The high false positive rate may obscure the predictive value of CA-125.Publication Metadata only Minimal invasive approaches in the management of cervical pregnancy Servikal Gebelik Yönetiminde Minimal İnvaziv Yaklaşım(2015-01-01) BATMAZ, Gonca; MOLLA, Fulya; MOLLA, Taner; AYDIN, SERDAR; Dansuk, RAMAZAN; AYDIN, SERDAR; DANSUK, RAMAZANPublication Metadata only Is procidentia a distinct disease Comparison of risk factors(2016-05-21T00:00:00Z) AYDIN, SERDAR; KILIÇ, GÖKHAN; DANSUK, RAMAZAN; GÖKMEN KARASU, AYŞE FİLİZ; AYDIN, SERDAR; KILIC, GÖKHAN; DANSUK, RAMAZAN; GÖKMEN KARASU, AYŞE FİLİZPublication Metadata only Effect of vaginal electrical stimulation on female sexual functions: a randomized study.(2015-02-01) Aydın, SERDAR; Arıoğlu, Aydın; BATMAZ, G; Dansuk, RAMAZAN; AYDIN, SERDAR; DANSUK, RAMAZANPublication Metadata only Mature ovarian cystic teratoma containing well-differentiated cerebellar tissue(2017-01-01) SONMEZ, F. Cavide; YILDIZ, PELİN; KIRAN, TUĞÇE; Arici, DİLEK SEMA; DANSUK, RAMAZAN; YILDIZ, PELİN; KIRAN, TUĞÇE; ARICI, DILEK SEMA; DANSUK, RAMAZANA 38-year-old female patient experienced groin pain; ultrasound imaging revealed a dermoid cystic mass in the right ovary and a cystectomy was then performed. Unusually, a mature cerebellum is found in the cyst wall. The pathological diagnosis was -mature cystic teratoma with well-differentiated cerebral and cerebellar tissue-. Glial tissue is a common neural component of teratomas, but a cerebellum is extremely rare in mature ovarian cystic teratomas. The authors report the case because of its rare component; they acknowledge that a cystic teratoma is the most common neoplasm of ovarian germ cells.Publication Metadata only Granulosa cell tumor presenting with ovarian torsion and de novo borderline mucinous ovarian tumor in the contralateral ovary.(2015-01-01) ATES, SEDA; Sevket, OSMAN; SUDOLMUS, S; SONMEZ, FATMA CAVİDE; DANSUK, RAMAZAN; ATEŞ, SEDA; ŞEVKET, OSMAN; SÖNMEZ, FATMA CAVİDE; DANSUK, RAMAZANPublication Metadata only Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics(2013-10-01) Ates, SEDA; Sevket, OSMAN; SUDOLMUS, Sinem; DANE, Banu; OZKAL, Fulya; Uysal, Omer; Dansuk, RAMAZAN; ATEŞ, SEDA; ŞEVKET, OSMAN; UYSAL, ÖMER; DANSUK, RAMAZANThis study presents the differences in clinical, endocrine and metabolic parameters among different polycystic ovary syndrome (PCOS) phenotypes in Turkish women. Four hundred and ten women with PCOS were evaluated, while 97 healthy women served as controls. PCOS were defined by oligo-anovulation (OA), hyperandrogenism (HA) and polycystic ovaries on ultrasound (PCO). Patients were subdivided into four phenotypes: OA + HA + PCO (phenotype 1), OA + HA (phenotype 2), HA + PCO (phenotype 3), OA + PCO (phenotype 4). Phenotypes 1-4 were present in 47.1%, 13.2%, 21.2% and 18.5% of patients, respectively. They were also divided into three groups according to the BMI (<25 kg/m(2); 25 <= and <= 30kg/m(2); and 430 kg/m(2)). ANOVA and Tukey post-hoc HSD tests were used. The LH levels and LH/FSH ratio were higher in phenotype 1 and 2 than phenotype 3. The LDL-C levels were higher in women with phenotype 1 and 4 than in women with phenotype 2. Women with BMI <25 kg/m(2) had higher levels of LH, LH/FSH ratio, and the HDL-C than other two groups. The levels of TG, LDL, fasting insulin and HOMA-IR increased with increasing BMI in four phenotypes. Results suggest that obesity seems to be the primary cause of metabolic disturbances in PCOS women.Publication Metadata only Olgu sunumu: 11 Haftalık skar gebeliğine bağlı spontan uterus rüptürü(2013-05-19) KILIC, GÖKHAN; Dane, Banu; Şevket, OSMAN; Dansuk, RAMAZAN; KILIC, GÖKHAN; ŞEVKET, OSMAN; DANSUK, RAMAZAN
- «
- 1 (current)
- 2
- 3
- »